Protagonist Therapeutics, Inc. (NASDAQ:PTGX) Sees Promising Future with FDA Approval
| Show full article |
|
This functionality is available for registred users only
|
-
Full nameProtagonist Therapeutics, Inc.
-
Registration countryUSA
-
IndustryPharmaceutical Preparation and Biotechnology
-
М/S&P/F
*** /*** /***









